Enhancement of levodopa stability when complexed with β-cyclodextrin in transdermal patches

References

• Kopin IJ. The pharmacology of Parkinson’s disease therapy: an update. Annu Rev Pharmacol Toxicol 1993;33:467–495.
   PubMed Web of Science ®Google Scholar
• Maynard RL. The Merck Index: 12th edition 1996. Occup Environ Med 1997;54:288–288.
   Google Scholar
• Kankkunen T, Huupponen I, Lahtinen K, et al. Improved stability and release control of levodopa and metaraminol using ion-exchange fibers and transdermal iontophoresis. Eur J Pharm Biopharm 2002;16:273–280.
   Web of Science ®Google Scholar
• Odak SP, Gidwani S. Enhancement of aqueous solubility of levodopa by using 2-HP-βCD. Int J Pharm Sci 2011;3:8.
   Google Scholar
• Pappert EJ, Goetz CG, Niederman F, et al. Liquid levodopa/carbidopa produces significant improvement in motor function without dyskinesia exacerbation. Neurology 1996;47:1493–1495.
   PubMed Web of Science ®Google Scholar
• Lee KE, Choi YJ, Oh BR, et al. Formulation and in vitro/in vivo evaluation of levodopa transdermal delivery systems. Int J Pharm 2013;456:432–436.
   PubMed Web of Science ®Google Scholar
• Muller T, Erdmann C, Bremen D, et al. Impact of gastric emptying on levodopa pharmacokinetics in Parkinson disease patients. Clin Neuropharmacol 2006;29:61–67.
   PubMed Web of Science ®Google Scholar
• Eisler T, Eng N, Plotkin C, Calne DB. Absorption of levodopa after rectal administration. Neurology 1981;31:215–217.
   PubMed Web of Science ®Google Scholar
• Iwase H, Sudo J-i, Terui J, et al. Transdermal absorption of L-dopa from a new system composed of two separate layers of L-dopa and hydrogel in rats. Drug Dev Ind Pharm 2000;26:755–759.
   PubMed Web of Science ®Google Scholar
• Loftsson T, Jarho P, Masson M, Jarvinen T. Cyclodextrins in drug delivery. Expert Opin Drug Deliv 2005;2:335–351.
   PubMed Web of Science ®Google Scholar
• Matsuda H, Arima H. Cyclodextrins in transdermal and rectal delivery. Adv Drug Deliv Rev 1999;36:81–99.
   PubMed Web of Science ®Google Scholar
• Uekama K, Otagiri M. Cyclodextrins in drug carrier systems. Crit Rev Ther Drug Carrier Syst 1987;3:1–40.
   PubMed Web of Science ®Google Scholar
• Govender T, Choonara YE, Kumar P, et al. Implantable and transdermal polymeric drug delivery technologies for the treatment of central nervous system disorders. Pharm Dev Technol 2016;7:1–11.
   Google Scholar
• Hadgraft J, Guy RH. 1989. Transdermal drug delivery: developmental issues and research initiatives New York: Dekker.
   Google Scholar
• Kevin I. Progress in the use of microemulsions for transdermal and dermal drug delivery. Pharm Dev Technol 2015;1:1–9.
   Google Scholar
• Abu-Huwaij R, Obaidat RM, Sweidan K, Al-Hiari Y. Formulation and in vitro evaluation of xanthan gum or carbopol 934-based mucoadhesive patches, loaded with nicotine. AAPS Pharm Sci Tech 2011;12:21–27.
   PubMed Web of Science ®Google Scholar
• Obaidat RM, Bader A, Al-Rajab W, et al. Preparation of mucoadhesive oral patches containing tetracycline hydrochloride and carvacrol for treatment of local mouth bacterial infections and candidiasis. Sci Pharm 2011;79:197–212.
   PubMedGoogle Scholar
• Obaidat RM, Wafa A-R, Mai K, Rana A-H, et al. A promising local preparation of mucoadhesive oral patches for treatment of periodontal disease. Eur J Parenteral Pharm Sci 2010;15:7.
   Google Scholar
• Wu G, Robertson DH, Brooks CL, 3rd, Vieth M. Detailed analysis of grid-based molecular docking: a case study of CDOCKER-A CHARMm-based MD docking algorithm. J Comput Chem 2003;24:1549–1562.
   PubMed Web of Science ®Google Scholar
• Berman H. The Protein Data Bank: a historical perspective. Acta Crystallogr A 2008;64:88–95.
   PubMedGoogle Scholar
• Banerjee A, Mikhailova E, Cheley S, et al. Molecular bases of cyclodextrin adapter interactions with engineered protein nanopores. Proc Natl Acad Sci USA 2010;107:8165–8170.
   PubMed Web of Science ®Google Scholar
• Grant GH, Richards WG. 1998. In: Compton R, Davies S, Evans J, Gladden L, eds. Computational chemistry. Oxford: Oxford Science Publications.
   Google Scholar
• Jorgensen WL, Chandrasekhar J, Madura JD, et al. Comparison of simple potential functions for simulating liquid water. J Chem Phys 1983;79:926–935.
   Web of Science ®Google Scholar
• Ryckaert J-P, Ciccotti G, Berendsen HJC. Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J Comput Phys 1977;23:327–341.
   Web of Science ®Google Scholar
• Crowley M, Darden T, Cheatham T, Deerfield D. Adventures in improving the scaling and accuracy of a Parallel Molecular Dynamics Program. J Supercomput 1997;11:255–278.
   Web of Science ®Google Scholar
• Fadrna E, Hladeckova K, Koca J. Long-range electrostatic interactions in molecular dynamics: an endothelin-1 case study. J Biomol Struct Dyn 2005;23:11.
   Web of Science ®Google Scholar
• Faria S, de Oliveira Petkowicz CL, de Morais SAL, et al. Characterization of xanthan gum produced from sugar cane broth. Carbohydr Polym 2011;86:469–476.
   Web of Science ®Google Scholar
• Gómez-Carracedo A, Alvarez-Lorenzo C, Gómez-Amoza JL, Concheiro A. Glass transitions and viscoelastic properties of carbopol and noveon compacts. Int J Pharm 2004;274:233–243.
   PubMedGoogle Scholar
• Kamphorst AO, Mendes de Sá I, Faria AMC, Sinisterra RD. Association complexes between ovalbumin and cyclodextrins have no effect on the immunological properties of ovalbumin. Eur J Pharm Biopharm 2004;57:199–205.
   PubMed Web of Science ®Google Scholar
• Ilbasmis-Tamer S, Tugcu-Demiroz F, Tuncer Degim I. Carbon nanotube membranes to predict skin permeability of compounds. Pharm Dev Technol 2016;1:1–11.
   Google Scholar
• Kumari B, Kesavan K. Effect of chitosan coating on microemulsion for effective dermal clotrimazole delivery. Pharm Dev Technol 2016;21:1–10.
   Google Scholar
• Tobyn MJ, Staniforth JN, Baichwal AR, McCall TW. Prediction of physical properties of a novel polysaccharide controlled release system. I. Int J Pharm 1996;128:113–122.
   Web of Science ®Google Scholar
• Dandawate PR, Vyas A, Ahmad A, et al. Inclusion complex of novel curcumin analogue CDF and beta-cyclodextrin (1:2) and its enhanced in vivo anticancer activity against pancreatic cancer. Pharm Res 2012;29:1775–1786.
   PubMed Web of Science ®Google Scholar
• Schneider H-J, Hacket F, Rüdiger V, Ikeda H. NMR Studies of Cyclodextrins and Cyclodextrin Complexes. Chem Rev 1998;98:1755–1786.
   PubMed Web of Science ®Google Scholar
• Thakkar AL, Kuehn PB, Perrin JH, Wilham WL. Cycloheptaamylose-barbiturate inclusion complexes: solubility and circular dichroism studies. J Pharm Sci 1972;61:1841–1843.
   PubMed Web of Science ®Google Scholar
• Zarif Mohamed Sofian JMA, Shafee NS, Othman H, Abdul Razak S. Hydroxypropyl-βCD/levodopa complex: an experimental study. J Chem Pharm Res 2014;6:3.
   Google Scholar